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Muscle disease as a group is characterized by muscle weakness, muscle loss, and
impaired muscle function. Although the phenotype is the same, the underlying cellular
pathologies, and the molecular causes of these pathologies, are diverse. One common
feature of many muscle disorders is the mispositioning of myonuclei. In unaffected
individuals, myonuclei are spaced throughout the periphery of the muscle fiber such that
the distance between nuclei is maximized. However, in diseased muscles, the nuclei
are often clustered within the center of the muscle cell. Although this phenotype has
been acknowledged for several decades, it is often ignored as a contributor to muscle
weakness. Rather, these nuclei are taken only as a sign of muscle repair. Here we review
the evidence that mispositioned myonuclei are not merely a symptom of muscle disease
but also a cause. Additionally, we review the working models for how myonuclei move
from two different perspectives: from that of the nuclei and from that of the cytoskeleton.
We further compare and contrast these mechanisms with the mechanisms of nuclear
movement in other cell types both to draw general themes for nuclear movement and to
identify muscle-specific considerations. Finally, we focus on factors that can be linked to
muscle disease and find that genes that regulate myonuclear movement and positioning
have been linked to muscular dystrophy. Although the cause-effect relationship is largely
speculative, recent data indicate that the position of nuclei should no longer be considered
only a means to diagnose muscle disease.
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HISTORY
Myofibers are the cellular units of mature skeletal muscles. The
structure of myofibers, and the basic principles that govern the
development of myofibers, are conserved from Drosophila to
humans. Skeletal muscle accounts for nearly 50% of adult body
mass, and the organization of the myofibers is repetitive and
striking. This repetitive structure is most notably illustrated by
the myofibril network, the linear and repetitive arrangement of
sarcomeres and associated proteins that enable muscle contrac-
tion. The myofibril network of skeletal muscle garnered much
early attention and has been studied in detail since the early
1940s, when Ramsey and Street published their observations that
the length of the sarcomere corresponded to the physical out-
put of the muscle (Ramsey and Street, 1940). With improved
electron microscopy techniques to better understand subcellu-
lar organization, the structure of the myofibrils was examined
in more depth, culminating in development of the sarcomeric
sliding filament model described in 1954 (Huxley and Hanson,
1954; Huxley and Niedergerke, 1954). Importantly, work in the
field of muscle biology maintained its focus on correlating the
structure of the muscle with the function, or physical out-
put, of the muscle cell. Moving forward, the feature that the
functional output of muscle can be easily assessed makes mus-
cle an ideal tissue in which to understand additional aspects
of cellular structure and organization and how they impact
function.
With the contractile myofibrillary network described, and
the development of more sophisticated imaging techniques, fur-
ther definition of the myofiber structure and how that structure
impacts function has gained traction. Coincident with the abil-
ity to more precisely examine muscle structure, advancements in
sequencing and gene identification have made it evident that sar-
comere assembly and myofibril organization are not sufficient for
full muscle function. In fact, many mutations that cause muscle
disease do not appear to directly affect sarcomere structure. For
example, Emery-Dreifuss Muscular Dystrophy (EDMD) is char-
acterized by progressive muscle weakness, but the genes that are
mutated in patients with EDMD encode proteins that localize to
the nucleus rather than the sarcomere. Furthermore, at least a
subset of EDMD causing mutations do not impact the assem-
bly of the sarcomere (Gueneau et al., 2009). This makes clear
that sarcomere assembly on its own is not sufficient for mus-
cle cells to generate maximal force and indicates that additional
aspects of cellular organization impact muscle physiology and
likely underlie many muscle diseases. Thus, to fully understand
general muscle biology, and muscle disease pathogenesis specifi-
cally, we must determine how muscle cells become organized and
the relative contributions of each aspect of organization to muscle
function.
Like all eukaryotic cells, myofibers require several organelles
that compartmentalize different cellular functions. For example,
mitochondria compartmentalize energy production, the nuclei
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compartmentalize gene regulation, the sarcoplasmic reticulum
compartmentalizes calcium storage and release, and the Golgi
apparatus compartmentalizes protein sorting. Each of these
organelles is essential to proper muscle function. This fact is
illustrated by the identification of mutations in genes related to
each organelle that cause muscle disease (Cohen et al., 2013;
Gazzerro et al., 2013; Schreiber and Kennedy, 2013). Although
the metabolic importance of muscle has been recognized for
decades, and significant information regarding the relationship
between mutations in metabolic enzymes and muscle disease
exists (Muntoni et al., 2011; Bonaldo and Sandri, 2013), the role
of general muscle architecture in muscle function is less clear.
Little is known regarding the aspects of organization that are
essential, how each organelle contributes to muscle function, and
whether the positioning of different organelles are linked or occur
independently.
These are overarching questions that will require years of work
to understand as only recently have researchers begun studying
the positioning of organelles in muscle. This review will focus
on the organization of nuclei within the myofiber. Specifically, we
will explore the mechanisms by which nuclei are positioned, and
the evidence that the precise positioning of nuclei is essential for
proper muscle function.
NUCLEAR POSITIONING IN MUSCLE
Nuclei in muscle are positioned at the periphery of each myofiber.
Furthermore, these peripheral nuclei are positioned to maximize
the distance between adjacent nuclei (Bruusgaard et al., 2003).
Although it is not known why nuclei are positioned in this way,
there are intuitive and compelling possibilities to explain both
aspects of nuclear position. The myodomains theory states that
each nucleus nourishes a discrete portion of the muscle (Pavlath
et al., 1989) and provides a logical explanation for the maxi-
mizing of internuclear distances. If nuclei were clustered rather
than spaced evenly, different regions of the muscle would lack the
transcription and translation necessary to maintain the myofiber.
Regarding the positioning of the nuclei at the periphery of the
myofiber, rather than within the myofiber, it is intuitive that
nuclei in the center of the myofiber could act as physical obstacles
to contraction and therefore impedemuscle output. Alternatively,
maintaining nuclei at the muscle periphery may be a means to
protect nuclei from the force of contraction that they would need
to withstand in the central portion of the muscle. Importantly,
these options are not mutually exclusive.
Consistent with these potential functions for myonuclear posi-
tioning, biopsies of the muscles from patients with several dif-
ferent muscle disorders display large numbers of myofibers with
centrally positioned nuclei (>25% compared to <3% in unaf-
fected individuals). Mispositioned nuclei were originally noted
with respect to muscle disease by Dr. Spiro (Spiro et al., 1966)
regarding a patient with Myotubular Myopathy, one of a sub-
set of muscle diseases that would become collectively referred
to as Central Nuclear Myopathies (CNM). However, centrally
positioned nuclei are not unique to CNM and have been noted,
and are prominent, in many distinct muscle disorders. Moreover,
central nuclei have been routinely used for nearly 50 years as
a pathological marker for differentiating muscle disorders from
neurological disorders (Dubowitz et al., 2007). Indeed, muscle
biopsies from patients with most muscle disorders, including rel-
atively common disorders such as DuchenneMuscular Dystrophy
(DMD) (Wang et al., 2000), Becker Muscular Dystrophy (BMD),
and EDMD (Gueneau et al., 2009), show nuclei prominently
within the center of individual muscle fibers.
However, despite the prevalence of centrally positioned nuclei
in the myofibers of patients suffering from disparate muscle dis-
eases, the importance of nuclear positioning to disease pathogen-
esis andmuscle weakness is not clear. Moreover, there is little to be
found in the scientific literature exploring the role of nuclear posi-
tioning in muscle function or disease. This is in part explained by
the prevailing hypothesis that is used to explain centrally posi-
tioned nuclei: central nuclei are considered to be merely a marker
of ongoing myofiber repair. This assumption is well supported
by the general mechanisms of muscle development and repair
during which all muscle nuclei undergo at least three dramatic
movements.
Multinucleate muscle fibers form from the fusion of mononu-
cleated myoblasts rather than through nuclear divisions in the
absence of cytokinesis as was once thought (Capers, 1960). Upon
fusion, each newly incorporated nucleus is actively moved to
the center of the immature myotube (Kelly and Zacks, 1969;
Cadot et al., 2012) (Figure 1). Following many fusion events, the
myotube will mature into a myofiber. Historically, this matura-
tion process is identified by the development of a dense myofibril
network throughout the cell. However, this maturation process
also correlates with the second type of nuclear movement during
which nuclei are moved from the center of the myofiber to the
periphery (Capers, 1960) and the third movement in which the
distance between adjacent nuclei is maximized (Bruusgaard et al.,
2003) (Figure 1). It is not clear whether the movement of the
nuclei to the periphery and the assembly of the myofibril network
are functionally linked and/or whether one process is dependent
on the other. Yet, the coincident nature of these two events and
the prevalence of aberrant nuclear positioning in individuals with
muscle disease, suggest that the peripheral localization of nuclei
and themaximizing of internuclear distance are important factors
in muscle development.
Following the movement of nuclei to the muscle periphery, a
small subset of muscle nuclei will undergo an additional move-
ment. These myonuclei can move as either individuals or as
clusters to the Neuromuscular Junction (NMJ) and stably local-
ize there as clusters of between 3 and 8 nuclei (Englander and
Rubin, 1987). This last movement to the NMJ is an active pro-
cess, and these nuclei have unique transcriptional profiles and
different levels of nuclear membrane proteins compared to the
majority of the muscle nuclei (Sanes et al., 1991; Moscoso et al.,
1995). Furthermore, it has been demonstrated that the position-
ing of these nuclei is essential for synaptic transmission (Jevsek
et al., 2006) and that the absence of nuclei clustered at the NMJ
correlate with neuro-muscular disease (Grady et al., 2005; Zhang
et al., 2007).
Similar nuclear movements are seen during myofiber repair
(Figure 1). First, activated satellite cells fuse with the damaged
myofiber (Yin et al., 2013). However, rather than maintaining
its position at the myofiber periphery where it fused, a newly
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FIGURE 1 | Position of nuclei during muscle development as seen in
cross-section (left) and longitudinal samples (right). As new nuclei
(pink) are incorporated from myoblasts during fusion, they are rapidly
moved to the center of the myotube by a process that requires the
microtubule cytoskeleton (green). Thus, in the myotube, the nuclei are
aligned in the center of the cell. As the myotube matures into a myofiber
with the assembly of the sarcomere (blue), the nuclei move to the
periphery of the muscle and reside directly above the sarcolemna (gray) and
space to maximize the internuclear distance. Coincident with these nuclear
movements, the microtubule cytoskeleton becomes highly ordered.
Microtubules are nucleated at or near the nuclear envelope with some
overlap of microtubules emanating from adjacent nuclei. Additionally,
microtubules extend to the sarcomeres and run parallel to these highly
ordered actin-myosin based structures. During repair, newly incorporated
nuclei undergo movements similar to the movements of nuclei in the
developing muscle. New nuclei are incorporated into the myofiber as
myotubes fuse with the myofiber. The newly incorporated nuclei move to
the center of the myofiber before moving out to the myofiber periphery in
two separate microtubule-dependent processes.
incorporated nucleus is moved to the center of the myofiber
before being moved back out to the cell periphery (Dubowitz
et al., 2007). The reason for these long-range nuclear move-
ments is not known. However, cross-sectional analysis reveals that
many more myofibers will have centrally positioned nuclei when
a muscle is undergoing repair compared to steady-state mus-
cles. Thus, centrally positioned nuclei provide an easy assay to
determine which myofibers are undergoing repair in response to
either disease or physical insult (Dubowitz et al., 2007).
For all of these reasons, it has been presumed that centrally
positioned nuclei are a consequence of continual myofiber repair
in patients with muscle disease. Therefore, the possibility that
mispositioned nuclei contribute to muscle weakness and dis-
ease have been ignored. However, that both nuclear movements
are maintained in already mature myofibers suggests that there
is a biological necessity to these movements. Significant energy
is spent moving nuclei to the center of the myofiber and back
to the periphery indicating that nuclear movement in muscle is
necessary for proper muscle function. It is therefore essential to
understand the mechanisms that drive these nuclear movements
and the biological significance of these nuclear movements to
fully understand and treat muscle disease.
Furthermore, many genes that are mutated in patients with
muscle disease encode proteins that localize to the nucleus. The
first identified proteins that localize to the nucleus and cause
muscle disease have known roles in regulating gene expression
(Maraldi et al., 2002; Tsukahara et al., 2002). Therefore, the initial,
and still enticing, hypothesis was that muscle diseases associ-
ated with these mutations resulted from aberrant gene regulation.
However, proteins that localize exclusively in the outer nuclear
envelope and regulate the interactions between the nucleus and
the cytoskeleton have recently been identified as mutated in
patients with muscle disease (Wheeler et al., 2007; Zhang et al.,
2007; Puckelwartz et al., 2009). Because these genes do not
directly interact with the genome, these data raise the possibility
that the nucleus may have a role in muscle development and func-
tion independent of its general role in gene regulation and might
suggest a role for nucleus-cytoskeleton interactions and nuclear
positioning in muscle development and disease pathogenesis.
We will review the mechanisms of nuclear positioning, specif-
ically in muscle, from the perspective of both the nucleus and the
cytoskeleton. Although we will discuss the mechanisms of nuclear
movement in broad strokes, we will further focus the discus-
sion toward genes known to be mutated in patients with muscle
disease.
THE NUCLEUS
It is intuitive that proteins of the nuclear envelope will participate
in the movement and positioning of nuclei. With few exceptions
in which nuclei are moved by bulk movement of the cyto-
plasm (Ramos-García et al., 2009), nuclear envelope proteins are
required for the nucleus to interact with the cytoskeleton. In turn,
the cytoskeleton provides the force to move nuclei, but requires
specific and often highly regulated interactions with the nuclei
(Gundersen andWorman, 2013). This is true in muscle also. Both
the LINC complex (Linker of nucleoskeleton and cytoskeleton;
reviewed Tapley and Starr, 2013), and the nucleoskeleton, which
is a filamentous network of proteins that provides structure to
the nucleus, are essential for nuclear movement and positioning
in muscle cells. Moreover, mutations in several of these proteins
have been identified in patients with muscle disease, specifically
EDMD (Stewart et al., 2007).
THE LINC COMPLEX
The LINC complex is composed of Nesprin proteins (also known
as Klarsicht, Anc, and Syne Homology (KASH) proteins) that
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span the outer nuclear envelope and SUN proteins that span the
inner nuclear envelope. Nesprin proteins come in many isoforms.
Mammals have at least four different Nesprin genes and each
of these genes is differentially spliced to form in total dozens of
Nesprin proteins. Similarly, SUN proteins exist in at least two dif-
ferent varieties from two different genes termed Sun1 and Sun2.
The LINC complex and its general roles in nuclear positioning
have been reviewed (Tapley and Starr, 2013), but we will focus
here in greater detail on the data from muscle systems and its
impact on muscle function.
Capitalizing on work in C. elegans (Starr et al., 2001; Starr and
Han, 2002), the role of the Nesprin protein, Syne-1, was examined
in mouse muscles. Expression of a dominant negative Syne-1 pro-
tein, which can localize to the nucleus but cannot interact with
the cytoskeleton, displaced endogenous Syne-1 from the nucleus
without generally disrupting nuclear structure. The disruption
of endogenous Syne-1 localization did not appear to dramati-
cally impact the peripheral localization of nuclei nor did it affect
their general spacing. However, the clustering of nuclei at the
NMJ was lost (Grady et al., 2005). Further analysis found that
genetic deletion of the Syne-1 KASH domain, the domain that
enables localization to the nuclear envelope, caused both synaptic
and non-synaptic nuclei to be mispositioned (Zhang et al., 2007;
Puckelwartz et al., 2009). Similarly, deletion of both SUN pro-
teins, Sun-1 and Sun-2, resulted in fewer nuclei at the NMJ and
the clustering of nuclei throughout the muscle fiber (Lei et al.,
2009). Finally, although disruption of Syne-1 did not impact Sun-
1 or Sun-2 localization (Grady et al., 2005), the deletion of Sun1/2
decreased the localization of Syne-1 to the nucleus. However,
neither Sun1/2 deletion nor Syne-1/Syne-2 deletion impacted
the organization of the nucleoskeleton (Lei et al., 2009). This
indicates that the localization of proteins necessary for nuclear
movement in muscle proceeds in a unidirectional manner from
the nucleoplasm to the cytoskeleton.
The role of the LINC complex in positioning muscle nuclei
is not confined to in vivo mouse muscles. The same proteins
have been shown to be essential for moving nuclei in the mouse
cell culture system of C2C12 myotubes. Specifically, it has been
demonstrated that disruption of the LINC complex by expression
of a dominant negative Syne-1 protein, similar to the experiment
carried out in vivo, causes nuclei in vitro to move less dynam-
ically and therefore to cluster (Wilson and Holzbaur, 2012).
Similarly, in developing Drosophila larvae, deletion of the KASH
domain from either of two KASH domain proteins in the genome
(Klarsicht and Msp-300) results in clustered nuclei in the larval
muscles (Elhanany-Tamir et al., 2012). Furthermore, mutation
of the Drosophila SUN protein Klaroid, affected the position
of nuclei in the embryonic musculature (Elhanany-Tamir et al.,
2012).
The precise role of these LINC complex proteins during
nuclear movement inmuscles is not known. However, in a general
sense, they enable the nucleus to interact with the cytoskeleton,
which provides the force to move nuclei. For example in the
C2C12 culture system, it has been demonstrated that KASH pro-
teins enable the microtubule motors Kinesin-1 and cytoplasmic
Dynein to interact with and move nuclei (Wilson and Holzbaur,
2012). This is consistent with data from several other systems
including C. elegans (Meyerzon et al., 2009; Fridolfsson et al.,
2010) and mammalian neurons (Zhang et al., 2009; Yu et al.,
2011). But the data from Drosophila larval muscles suggest an
alternative mechanism in which the KASH proteins are necessary
to maintain microtubule-nucleus interactions (Elhanany-Tamir
et al., 2012). Supporting this hypothesis, many KASH domain-
containing proteins harbor domains that can directly interact
with the cytoskeleton. However, despite the dramatic effect that
the loss of KASH proteins have on microtubule organization, the
effect could be indirect and result from inefficient recruitment
of the aforementioned microtubule motors. Further work is nec-
essary to distinguish these mechanisms and/or demonstrate how
the two mechanisms are coordinated.
Another confounding issue in these data is that the initial study
in mouse, in which Syne-1 and Syne-2 were displaced from the
nuclear envelope by the expression of the Syne-2 KASH domain,
only affected the positioning of the synaptic nuclei. It is not clear
why the displacement of the endogenous protein from the nuclear
envelope causes a different phenotype than does the expression
of a KASH-less protein. A simple interpretation of these data is
that a portion of the endogenous protein remains localized to
the nucleus even in the presence of the dominant negative, and
that the synaptic nuclei are more sensitive to levels of endogenous
Syne-1 and Syne-2. However, further work is necessary to fully
understand these data.
THE NUCLEOSKELETON
The nucleoskeleton is a meshwork of proteins contained within
the nucleus and adjacent to the inner nuclear membrane that
provides the nucleus with its shape and its ability to withstand
mechanical stresses. The primary components of the nucleoskele-
ton are the nuclear lamin proteins which exist in several varieties.
There are two B-type lamins that originate from two genes,
LMNB1 and LMNB2. The A-type lamins, Lamin A and Lamin
C, are, respectively, the immature and fully processed gene prod-
ucts of the LMNA gene and will be the forms discussed here; it
is these proteins that directly contribute to nuclear positioning in
muscles, andmutations in the LMNA gene result in the autosomal
dominant form of EDMD (Stewart et al., 2007).
Work in cell culture has demonstrated that in the absence of
Lamin A/C, nuclear movement is inhibited (Lee et al., 2007; Hale
et al., 2008; Houben et al., 2009; Folker et al., 2011), the abil-
ity of the nucleus to withstand physical stress is limited (Broers
et al., 2004; Lammerding et al., 2004), and the ability of the cell
to organize its genome is compromised (Gnocchi et al., 2011;
Mattout et al., 2011). Each of these biological functions has been,
and continues to be, explored as possible pathogenic mechanisms
of LMNA mutations and significant data support each of these
hypotheses.
The first Lmna−/− mouse study was published in 1999 and
changes in both nuclear structure and nuclear localization were
noted. Moreover, mice lacking Lamin A/C were described as dys-
trophic (Sullivan et al., 1999). All of these characteristics were
similar to those described in human EDMD patients carrying
LMNA mutations (Bonne et al., 2000). Similarly, larval muscles
in Drosophila which lack Lamin C (the only A-type lamin in
Drosophila) have nuclei with variable and distorted structures that
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are commonlymispositioned (Dialynas et al., 2010; Zwerger et al.,
2013). Yet, none of these studies have been able to clarify the rel-
ative contributions of distorted nuclear structure and aberrant
nuclear positions to muscle disease.
Attempts to clarify this question using cell culture based
systems have added support for each possibility. For exam-
ple, more detailed rheological analysis has clearly demonstrated
that not only does the loss of Lamin A/C make cells and
their nuclei more sensitive to mechanical stress, but that muta-
tions which cause EDMD have the same effect (Zwerger et al.,
2013). Similarly, LMNA mutations that when heterozygous in
humans cause EDMD inhibit nuclear movement when expressed
in fibroblasts suggesting a dominant negative role for these muta-
tions. Interestingly, LMNA mutations that cause Dunnigan Type
2 Familial-Partial Lipodystrophy, also in a dominant negative
manner, have no effect on nuclear movement, suggesting that
mediating nuclear positioning or nuclear-cytoskeletal interac-
tions are a function of Lamin A/C that is particularly important
in muscle (Folker et al., 2011).
Finally, although the experiments in Drosophila do not dif-
ferentiate between effects on nuclear structure, gene regulation,
and nuclear position, they do provide insight toward the rele-
vance of nuclear position. As noted previously, the consensus has
been that the mispositioned nuclei in patients with muscle disease
are merely a result of ongoing myofiber repair. However, there is
no evidence that Drosophila larval muscles undergo repair. Yet,
the nuclei in Drosophila larval muscles are dramatically misposi-
tioned when Lamin C is absent or when disease causing variants
of Lamin C are expressed only in the muscle (Dialynas et al.,
2010). This suggests that myonuclear positioning is an active and
critically maintained process and that all nuclear mispositioning
is not merely a marker of ongoing muscle repair.
Taken together, these data make clear that Lamin A/C is essen-
tial for proper nuclear positioning in muscle. Additionally, and
most importantly for this discussion, is that the contribution of
Lamin A/C to nuclear position is inhibited by mutations that
cause muscle disease. This correlation suggests that the role of
Lamin A/C in positioning nuclei may contribute to muscle weak-
ness and disease. More generally, these data further suggest that
the positioning of the nucleus within the muscle may be funda-
mentally important and that aberrant nuclear positioning may
contribute to disease pathogenesis.
Proteins that interact with the Lamin A/C also cause muscle
disease and have also been implicated in regulating nuclear struc-
ture, gene expression and nuclear position (Zhong et al., 2010).
Emerin (EMD) is among the best described Lamin-interacting
proteins; it was identified as a gene mutated in patients with X-
linked EDMD prior to the identification of LMNA as the gene
responsible for the autosomal dominant form of EDMD (Bione
et al., 1994). Emerin null fibroblasts are similar to Lamin null
fibroblasts in that they fail polarize and instead form inefficient
nucleus-cytoskeleton interactions (Chang et al., 2013; Ho et al.,
2013). However, the analysis of Emerin and its functions in vivo
are limited when compared to Lamin A/C. Analysis of the Emerin
null mouse has likely lagged relative to the Lamin null mouse due
to the lack of phenotype. Although the Emerin null mouse does
have delayed muscle regeneration (Melcon et al., 2006), there are
no overt dystrophic phenotypes (Melcon et al., 2006; Ozawa et al.,
2006). The reason for this discrepancy requires further examina-
tion, but perhaps Emerin is involved in enhancing or specifying
a specific Lamin A/C function. If Lamin A/C is contributing to
muscle function through multiple pathways, one might reason
that the effects of mutating each individual regulating protein
would be diminished relative to loss of Lamin A/C itself.
Unfortunately, it is not clear how mutations in EMD and
LMNA cause muscle disease. However, both genes are neces-
sary to maintain the structure of individual nuclei, to position
nuclei, and to maintain proper gene regulation as discussed
above. Perhaps these three aspects of nuclear biology in muscle
are critically linked.
Indeed, it has been argued that improper gene regulation in
Lmna null mice causes the clustering of nuclei. This clustering
is particularly evident near the NMJ, and nuclei in this location
vary from levels of almost no acetylated histone H3 to high lev-
els of acetylated histone H3. This is contrasted by the nuclei in
WT muscles which have consistent and moderate levels of acety-
lated histone H3 (Gnocchi et al., 2011). However, it is equally
plausible that improper positioning leads to the change in gene
expression. There is in fact clear evidence that nuclear posi-
tion can influence gene expression. For example, nuclei at the
NMJ have a unique transcriptional profile relative to the non-
synaptic nuclei (Jevsek et al., 2006). Perhaps nuclei being in close
proximity can communicate and coordinate their transcriptional
output such that individual nuclei down-regulate transcription.
Alternatively, nuclei may sense the proximity of other nuclei and
up-regulate transcription in an effort to repair or remodel the
muscle. Although the cause-effect relationship is not clear, that
both phenotypes are common and can be caused by mutations in
the nucleoskeleton highlights the need to better understand how
these processes relate to muscle function. The ability to affect the
position of nuclei without directly affecting their transcriptional
profile, and vice versa, is essential to gaining a full understanding
of this relationship.
THE CYTOSKELETON
Movement of nuclei by the cytoskeleton is seen in eukaryotes
ranging from yeast to mammals and is relevant to processes rang-
ing from DNA segregation during mitosis to cellular locomotion
(Gundersen and Worman, 2013). In the next several paragraphs
we will consider how the cytoskeleton moves nuclei and will focus
on mechanisms determined in muscle systems.
Two different cytoskeletal networks have been demonstrated
to drive nuclear movements. Most nuclear movements, in both
muscles and other tissues, are driven by microtubules and their
associated proteins and motors. Other nuclear movements and
positioning events require the action of the actin cytoskeleton
and its associated factors. In most cellular contexts the actin net-
work and the microtubule network are intimately connected,
often co-regulated, and can directly impinge on the activity of
the other, making it difficult to discern the specific effects of
either network (Rodriguez et al., 2003). Still, several mecha-
nisms of either nuclear movement or nuclear positioning have
been elucidated and attributed to one cytoskeletal network or the
other.
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MICROTUBULES
The organization of the microtubule network in muscle cells is
different from that in most other cell types. Most eukaryotic cells
have a single microtubule organizing center (MTOC) from which
most microtubules emanate and at which microtubule minus-
ends are anchored. In higher eukaryotes this is accomplished by
the centrosome and in many lower eukaryotes such as yeast, this
is accomplished by an analogous structure called the spindle pole
body. Muscle cells do not have a single MTOC. This is not merely
a result of having many nuclei because each nucleus has several
associated MTOCs. In culture, after myoblasts fuse to a growing
myotube they disassemble their centrosome and redistribute their
pericentriolar material and γ-tubulin around the entire nuclear
envelope (Tassin et al., 1985) and in smaller quantities to the
Golgi apparatus (Ralston et al., 2001). Similar organization is seen
in vivo, where each nuclear envelope and Golgi apparatus thus
serves as a MTOC with microtubules emanating frommany loca-
tions on both the nucleus and the Golgi apparatus (Oddoux et al.,
2013). Given that there are often tens to hundreds of nuclei in a
given muscle, mature muscles have microtubules that originate
from many distinct locations.
Except for the number of MTOCs, the microtubules emanat-
ing from the nuclei behave similarly to those in other cell types.
Microtubules grow in all directions with equal probabilities and
have similar dynamics to microtubules in standard cell culture
experiments (Wilson and Holzbaur, 2012) and in vivo (Oddoux
et al., 2013; Folker et al., 2014). However, this is not the only
microtubule network in muscle cells. In the mature muscles of
mammals and flies, a second microtubule network is present
within the myofibril network and is characterized by a signifi-
cantly different population of microtubules. Microtubules in this
region are less dense and are oriented such that they run along the
length of the myofibrils, with occasional microtubules running
transversely between the myofibrils (Kano et al., 1991; Metzger
et al., 2012). Additionally, it appears that many of the micro-
tubules that exist in this central portion of the muscle originate
from perinuclear regions near the muscle periphery (Kano et al.,
1991). Thus, it is likely that the nuclei serve as the MTOC for
bothmicrotubule networks that are observed within skeletal mus-
cle. Furthermore, given that microtubules are directly interacting
with nuclei in muscles, the organization and activity of the micro-
tubule cytoskeleton will inevitably impact the spatial distribution
of nuclei.
The role of microtubules in positioning muscle nuclei dates
back to early studies using explants from chick embryos which
demonstrated that nuclei moved, rotated and eventually became
fixed in position (Capers, 1960). Subsequent analysis using cul-
tures derived from mice and rats found that nuclei underwent
similar movements and further demonstrated that the dynamic
movements required microtubules. Specifically, it was shown
that if microtubules were depolymerized with colchicine, nuclear
movements and rotations stopped (Englander and Rubin, 1987).
Remarkably, little more was learned regarding how the micro-
tubule cytoskeleton moves muscle nuclei until recently. New
work has confirmed a role for microtubules in moving muscle
nuclei and expanded the mechanistic understanding of the pro-
cess. Generally, the proteins that move nuclei in other systems
(Gundersen and Worman, 2013) contribute to the movement of
nuclei in muscle systems.
The two factors that generate most of the force that moves
nuclei in muscles are the two microtubule motors, Kinesin-
1 that moves toward microtubule plus-ends, and cytoplasmic
Dynein that moves toward microtubule minus-ends. These two
motors are also essential for microtubule based nuclear move-
ment in virtually every other system (Tapley and Starr, 2013),
suggesting that the basic mechanisms are conserved among cell
types and species. However, there are several unique aspects to
nuclear movements in muscle. Furthermore, recent analyses have
described distinct mechanisms that contribute to different types
of nuclear movements in muscle both in vivo during embryonic
Drosophila development and in mouse culture systems (Cadot
et al., 2012; Folker et al., 2012; Metzger et al., 2012; Wilson and
Holzbaur, 2012).
One of the most striking aspects of nuclear movement in
muscle is that the nuclei dynamically rotate in three dimensions
during translocation. This aspect was also first noted in cultures
derived from chick embryos (Capers, 1960) but has recently been
described in mammalian culture systems (Wilson and Holzbaur,
2012) and developing Drosophila embryos (Folker et al., 2014).
Furthermore, moving myonuclei in the developing Drosophila
embryo have a defined leading and lagging edge which enables
rapid changes in nuclear shape. These shape changes require the
coordinated actions of Kinesin and Dynein at the nucleus, an
aspect of nuclear movement that has to date only been described
in developing muscle (Folker et al., 2014).
The role of these rotations and shape changes are not clear.
However, each of these reports hypothesizes that these behav-
iors provide nuclei with a unique ability to maximize movement
velocity in dense cellular and embryonic environments. Similar
rotations of translocating nuclei have been noted in C. ele-
gans where rotations were also proposed as a means to navigate
the dense cellular environment (Fridolfsson and Starr, 2010).
Additionally, dramatic changes in nuclear shape have been noted
in neurons (Tsai et al., 2007) where they seem to be essential to
move through spatially restricted environments.
Although similar behaviors have been noted in other systems,
the mechanisms and persistence of these behaviors in muscle
are different. For example, the nuclear rotations in C. elegans
appear to occur only to navigate past blockages whereas in mus-
cle, nuclear rotations are common and are not strictly correlated
with defined translocation (Wilson and Holzbaur, 2012; Folker
et al., 2014). Additionally, the changes in nuclear shape during
translocation in neurons are dependent only on the activity of
Dynein from a position distant from the nucleus (Tsai et al.,
2007), whereas the analogous behavior inmuscle requires the spa-
tially segregated activities of Dynein and Kinesin (Folker et al.,
2014). These distinctions may be driven by the multinucleate
nature of muscle and may reveal information regarding inter-
actions between nuclei. If nuclei do indeed interact with one
another, it is likely that nuclear position affects these interactions.
Altered interactions between nuclei could greatly influence the
maintenance of myodomains as well as the transcriptional pro-
file of individual nuclei, and thus have dramatic effects on muscle
structure and function.
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Kinesin and Dynein move nuclei in muscle systems but they
contribute to different types of movement using different arrays
of regulators/accessory proteins. Consider again the types of
nuclear movement in the muscle. In simple terms, there is
(1) movement to the center of the myotube/myofiber following
fusion, (2) movement of each nucleus to the muscle periphery,
(3) equidistant spacing of nuclei, and (4) movement of nuclei to
the NMJ. Experiments using mouse culture systems have iden-
tified the small GTPase Cdc42, and the polarity proteins Par6
and Par3, as necessary for newly fused nuclei to move toward
the center of the myotube (Cadot et al., 2012). Each of these
proteins contributes to nuclear movement in other systems by
enabling Dynein anchored at the cell cortex to pull nuclei that
are attached to microtubule minus-ends toward itself (Kotak and
Gönczy, 2013). Nuclei in muscle are moved by a similar mech-
anism, but the details may be slightly different. In immature
myotubes, Dynein, Par3, and Par6 localize to the already incor-
porated nuclei. From the central cluster of nuclei, Dynein pulls
the new nuclei to the myotube center (Cadot et al., 2012). In
vivo experiments looking at embryonic muscle development in
Drosophila suggest mechanisms more analgous to those in C. ele-
gans. Specifically, Dynein is anchored at the muscle cortex by
Pins and pulls microtubule minus-ends and the attached myonu-
clei toward the end of the muscle dependent on the microtubule
plus-end tracking protein, CLIP-190 (Folker et al., 2012). The dif-
ference between the data in mammalian cell culture and that in
developing Drosophila embryos may result from in vitro/in vivo
differences or because different types of nuclear movement are
being analyzed. That other mechanisms seem to be conserved
between the two systems suggests that the latter may be the case.
The study of nuclear movement in muscle has revealed novel
behaviors of moving nuclei (Wilson and Holzbaur, 2012; Folker
et al., 2014), and has also identified proteins with novel roles
in nuclear movement. MAP7/Ensconsin was long ago identi-
fied as a microtubule associated protein (Bulinski and Bossler,
1994), but a cellular role for this protein had not been identified.
Work in both the developing muscles of the Drosophila embryo
and mammalian cell culture have found MAP7/Ensconsin to
be essential for nuclear movement in muscle (Metzger et al.,
2012). Additionally, unlike Cdc42, Par6, Par3, and Dynein,
MAP7/Ensconsin does not affect the movement of nuclei toward
the muscle center, but is essential only for the spacing of nuclei
throughout the muscle by a mechanism identified in both devel-
oping Drosophila and mammalian culture systems further illus-
trating that different types of nuclear movement in muscle are
driven by distinct mechanisms (Cadot et al., 2012; Metzger et al.,
2012). The mechanism by which MAP7 contributes to nuclear
movement is not known. However, MAP7 can physically interact
with Kinesin (Metzger et al., 2012), and the Drosophila homolog
of MAP7, Ensconsin, can increase Kinesin-microtubule interac-
tions, thus resulting in increased Kinesin motility (Sung et al.,
2008). Finally, a fusion protein containing theMAP7microtubule
binding domain and the Kinesin motor domain can move nuclei
(Metzger et al., 2012). These data have all been used to sug-
gest that MAP7/Ensconsin helps spread and maintain the spacing
between nuclei by enabling Kinesin to slide antiparallel micro-
tubules which emanate from neighboring nuclei, similar to the
way in which Kinesin and Ensconsin transport microtubules in
neurons (Barlan et al., 2013). The result of this sliding is the push-
ing apart of adjacent nuclei similar to the mechanism by which
mitotic spindles are elongated in cell divisions (Metzger et al.,
2012).
To date, mutations in Dynein and its regulatory proteins,
Kinesin and its regulatory proteins, and MAP7/Ensconsin have
not been identified in patients with muscle disease. That is likely
due to the very fundamental roles each of these proteins play in
all cells. Thus, if the ability of Dynein and/or Kinesin to move
nuclei is eliminated, its ability to move other cargos through-
out the cell are also likely compromised. However, these analyses
have provided insight to the relevance of nuclear positioning in
muscle. Tissue specific depletions of these proteins in Drosophila
have confirmed that these proteins have a muscle autonomous
effect on nuclear positioning without affects on nuclear mor-
phology (Folker et al., 2012; Metzger et al., 2012). Yet, the ability
of Drosophila lacking these proteins specifically in the muscle to
move is inhibited (Folker et al., 2012; Metzger et al., 2012). This
is not to suggest that nuclear morphology and gene regulation are
not essential and relevant contributions to disease. Instead these
data makes evident that the clustering of nuclei, in the absence of
other obvious defects in muscle architecture, does inhibit muscle
function.
ACTIN
There are far fewer examples of actin-dependent nuclear move-
ment compared to microtubule-dependent nuclear movement
throughout biology. Furthermore, there is no evidence of actin-
dependent nuclear movement in muscle. However, there is evi-
dence that actin contributes to the anchoring of nuclei in different
locations (Zhang et al., 2002, 2010; Puckelwartz et al., 2009).
Additionally, there is substantial evidence from experiments in
cell culture that nuclear proteins interact with actin and that these
interactions can influence nuclear structure (Nikolova et al., 2004;
Lüke et al., 2008; Khatau et al., 2009), cellular rheology (Maniotis
et al., 1997; Lammerding et al., 2004), and nuclear movement and
positioning (Luxton et al., 2010).
In fibroblasts, actin moves the nucleus as an initial step in
cell migration (Gomes et al., 2005). Furthermore, this movement
requires the same LINC complex components that are mutated
in patients with muscle disease. As in muscle, the LINC com-
plex enables the direct interaction between the nucleus and the
cytoskeleton, but in this case the nucleus interacts with the actin
cytoskeleton rather than the microtubule cytoskeleton (Luxton
et al., 2010). Similarly, Lamin A/C is necessary for nuclear move-
ment in this system and contributes by serving as an anchor for
the LINC complex so that it can couple the movement of actin to
the nucleus. Essential to this review, mutations in Lamin A/C that
cause muscle disease also inhibit the ability of the nuclear lam-
ina to anchor the LINC complex (Folker et al., 2011). This raises
the possibility that the ability of Lamin A/C to anchor the LINC
complex so that force can be transmitted from the cytoskeleton to
the nucleus is fundamental to muscle biology and muscle disease
pathogenesis.
Only one report has suggested even indirect roles for actin in
regulating the position of myonuclei in vivo. It was demonstrated
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that the KASH domain containing protein, Msp-300, was essen-
tial for nuclear positioning in larval muscles. Although most of
this work focused on the effects that the loss of Msp-300 had
on the organization of microtubules, it also found Msp-300 to
be localized to the Z-disks suggesting a role in sarcomere orga-
nization (Elhanany-Tamir et al., 2012). Furthermore, although
Msp-300 did not interact directly with actin, it did interact with
actin via the thick filament protein, Titin and these interactions
may be necessary for proper nuclear positioning.
Although there is limited evidence for actin dependent nuclear
movement in muscle, the fact that genes identified as causes of
EDMD are essential for actin-dependent nuclear movement in
other systems is compelling. Furthermore, it has been reported
that mutations in each of these genes in addition to having effects
on the nucleus as discussed throughout this review, also affect
actin organization (Ho et al., 2013). And work in Drosophila and
mice has found that the genetic disruptions that cause nuclear
mispositioning (along with other effects) also impact the orga-
nization of the actin cytoskeleton (Dialynas et al., 2010). Thus,
despite far less evidence for actin dependent nuclear movement,
further exploration of this possibility is necessary.
CONCLUSION
The subcellular structure and organization of muscle has been
studied since the advent of microscopes. Although, the assembly
and organization of myofibrils which dominated early research
is still being examined, new avenues of research have emerged.
In general, the questions of where the different organelles are
located, why they are located in such a manner, how they become
localized, and whether the organization of different organelles
are linked have garnered increased focus. Yet, the complex orga-
nization of individual muscle cells, the multinucleate nature of
individual muscle cells, and the bundling and further bundling of
these cells have provided many obstacles to detailed understand-
ing of muscle development.
Nevertheless the technology and systems to address these ques-
tions are becoming available (Oddoux et al., 2013). Although
this review focused on how nuclei move and the correlations
between nuclear positioning and muscle disease, similar analyses
have been performed with respect to mitochondria (Pathi et al.,
2012), t-tubules (Flucher et al., 1994) and other organelles. We
have highlighted some of the data regarding the mechanisms of
nuclear movement in muscle and indicated that the basic prin-
ciples of nuclear movement are conserved between species and
between cell types. The conservation of the proteins used to move
nuclei provides a list of proteins to examine in systems of muscle
development. Furthermore, it expands the list of targets that we
should evaluate in patients suffering from muscle disease.
Indeed, many of the proteins that are necessary to move nuclei
are mutated in individuals with muscle disease. However, this
is almost exclusively true of those proteins that localize to the
nucleus and contribute from that location by regulating the inter-
actions between the nucleus and the cytoskeleton. The cytoskele-
tal proteins that contribute to nuclear movement in muscle have
not yet been linked to muscle disease. This is likely because muta-
tions that would affect the ability of the cytoskeleton to move
nuclei would also cause general developmental defects as has been
demonstrated for Kinesin (Wang et al., 2013). But it is important
that the contribution of these proteins to nuclear movement not
be ignored on grounds that they do not cause disease. With
regards to basic biology, these genes can provide a means to study
nuclear position in the absence of global effects on nuclear archi-
tecture and gene regulation. More therapeutically relevant, they
are essential for a process that is highly correlated with disease.
Thus, with sufficient understanding it may be possible to circum-
vent the disease causing mutations by targeting the cytoskeleton.
Despite the high correlation between aberrant nuclear
positioning and muscle disease the idea that nuclear position
in muscle is essential for muscle function will likely remain
controversial. Recent analyses in Drosophila which demonstrated
reduced muscle output when nuclei were mispositioned without
additional underlying defects (Metzger et al., 2012) may convince
some, but not all. However, reconsidering the process of muscle
repair may provide the most compelling evidence that nuclear
movement is important and essential, even if mispositioned
nuclei do not cause disease. Organisms, and cells, in general
optimize their energy usage. With that premise, it is unlikely
that nuclei would move to the center and then back out to the
periphery of an already mature myofiber. Energetically speaking
it would be far more efficient to incorporate a new nucleus at
the point of entry at which point the nuclei could undergo slight
movements to space along the myofiber. Nuclear movement to
the center and then back to the periphery of a muscle must be
essential to muscle development and repair. With newly found
focus we may soon understand the biological necessity of these
long range nuclear movements in muscle.
Finally, nuclear position is almost certainly not the final answer
with regards to muscle disease. But with the evidence that nuclear
positioning is essential to muscle function is increased, making
it time that the muscle biology community begin to consider
centrally localized nuclei as more than merely a marker of ongo-
ing muscle repair and as a phenotype that may influence muscle
function and health.
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